Simplex Trading’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$354K Sell
16,200
-40,300
-71% -$897K ﹤0.01% 3646
2025
Q4
$1.21M Buy
56,500
+11,100
+24% +$195K ﹤0.01% 2443
2025
Q3
$531K Sell
45,400
-23,600
-34% -$235K ﹤0.01% 3744
2025
Q2
$641K Buy
69,000
+49,900
+261% +$409K ﹤0.01% 3243
2025
Q1
$128K Buy
19,100
+18,500
+3,083% +$177K ﹤0.01% 4798
2024
Q4
$6K Sell
600
-400
-40% -$4.83K ﹤0.01% 7503
2024
Q3
$14K Sell
1,000
-30,000
-97% -$426K ﹤0.01% 6947
2024
Q2
$375K Buy
31,000
+28,700
+1,248% +$449K ﹤0.01% 3969
2024
Q1
$56K Sell
2,300
-4,900
-68% -$99.4K ﹤0.01% 6162
2023
Q4
$77K Sell
7,200
-700
-9% -$5.82K ﹤0.01% 5638
2023
Q3
$65K Buy
7,900
+7,500
+1,875% +$55.1K ﹤0.01% 5555
2023
Q2
$3K Buy
+400
New +$2.19K ﹤0.01% 8228
2022
Q4
Sell
-300
Closed -$1K 9727
2022
Q3
$1K Buy
+300
New +$1.41K ﹤0.01% 9550
2022
Q2
Sell
-3,100
Closed -$17K 10451
2022
Q1
$17K Buy
3,100
+2,500
+417% +$18.7K ﹤0.01% 8404
2021
Q4
$7K Buy
+600
New +$10.7K ﹤0.01% 9309

Other funds holding IMNM

Simplex Trading's IMNM Position: Q1 2026 in Review

Simplex Trading sold out of Immunome (IMNM) in Q1 2026, closing a stake of 23,401 shares — an estimated $521K sold.

Simplex Trading first reported a position in IMNM in Q2 2021 and held it in 17 quarters. The position peaked at $722K in Q3 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Simplex Trading reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 23,401 Immunome shares in Q1 2026, an estimated $521K.
  • Simplex Trading first reported a position in Immunome in Q2 2021 and held it in 17 quarters.
  • Simplex Trading's Immunome position peaked at $722K in Q3 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.